Loading stock data…
LifeVantage Corporation engages in the identification (LFVN)
$6.34+0.09 (+1.44%)
Market ClosedLast close Sep 8
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
LifeVantage Corporation in the Consumer Defensive sector is trading at $6.34 with a market capitalization of $72M. Wall Street consensus targets $7.50 (2 analysts), implying a +18.3% move over the next 12 months. The stock is currently 48% below its 52-week high of $12.10, remaining 8.2% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +18.3% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $43.72M↓ | $48.93M↑ | $47.56M↓ | $55.11M↓ | $58.44M |
| Gross Profit | $34.54M↓ | $36.21M↓ | $37.82M↓ | $44.05M↓ | $47.33M |
| Operating Income | $1.68M↑ | $487,000↓ | $2.27M↑ | $2.15M↓ | $4.05M |
| Net Income | $1.36M↑ | $276,000↓ | $2.15M↑ | $1.96M↓ | $3.47M |
Peer Comparison
Fundamentals
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internati...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$72.04M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Strong income play. Yield provides a meaningful total return floor.
2.37%
ROE
Elite ROE. Management converts capital into profit efficiently.
17.25%
Volume
Today's trading volume
105,869
Recent News
LifeVantage (LFVN) Q4 2026 Earnings Call Transcript
Revenue fell 23% as macroeconomic pressures weighed on orders and average order sizes.
LifeVantage Corporation Q4 2026 Earnings Call Summary
Moby summary of LifeVantage Corporation's Q4 2026 earnings call
Lifevantage Corp (LFVN) (Q4 2026) Earnings Call Highlights: Revenue Declines 23% Amid Strategic ...
New CEO outlines turnaround plan as subscription base remains resilient despite macroeconomic headwinds
Lifevantage Q4 Earnings Call Highlights
Lifevantage (NASDAQ:LFVN) reported lower fourth-quarter and fiscal 2026 results as the health and wellness company faced fewer orders, lower average order sizes and a difficult comparison against prior-year sales of its MindBody GLP-1 System. For the fourth quarter ended June 30, net revenue declin
LifeVantage Corporation (NASDAQ:LFVN) Pays A US$0.05 Dividend In Just Three Days
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...